pharma

Showing 15 posts of 2914 posts found.

merck_kgaa_pyramid_use_with_credit

Seven years later, EC gives approval for Merck KGaA’s MS drug

August 25, 2017
Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …

samsung_bioepis_engineer_4

Samsung completes hat-trick of big biosimilar approvals

August 25, 2017
Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical

Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …

manufacturing_image_1

‘Trade secret information’ to be shared between EMA and FDA

August 25, 2017
Manufacturing and Production, Medical Communications EMA, FDA, biotech, drugs, pharma, pharmaceutical

As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …

Roche receives FDA Priority Review for drug with potted history

August 24, 2017
Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical

Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …

astrazeneca_building_white

Extended use of AstraZeneca’s Brilinta reduces cardiovascular death risk

August 24, 2017
Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, life sciences, pharma, pharmaceutical

New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …

hiv_testing_kit

HIV home tests seized from market over potential risk

August 24, 2017
Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical

The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …

Novartis names new Chief Digital Officer

August 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment, digital pharma, life sciences, pharma, pharmaceuticals

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

Novartis gets EU nod for potential blockbuster breast cancer drug

August 24, 2017
Sales and Marketing CDK4/6, Novartis, biotech, breast cancer, drugs, pharma, pharmaceutical

Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …

640px-sq_lethal_injection_room

Janssen opposes use of its drug in state execution

August 23, 2017
Medical Communications, Research and Development, Sales and Marketing Janssen, etomidate, life sciences, pharma, pharmaceutical

Janssen has spoken out against plans to use an anaesthetic drug it invented over 50 years ago to execute prisoners, …

cancer-cell

Collaboration between Lilly and CRUK progresses to clinical trials

August 23, 2017
Research and Development Cancer Research UK, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress …

icr

Scientists discover ‘Achilles’ heel’ of oesophageal cancer

August 23, 2017
Research and Development ICR, Janssen, biotech, drugs, pharma, pharmaceutical

Researchers from The Institute of Cancer Research have potentially found a new use for Imbruvica, after discovering a weakness in …

shutterstock_236161768

Novartis launches first large-scale smartphone-based study in multiple sclerosis

August 23, 2017
Research and Development MS, Novartis, life sciences, multiple sclerosis, pharma, pharmaceuticals

Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …

anatomical-2261006_960_720

Ultragenyx stumbles in P3 trial for severe muscle disease

August 23, 2017
Research and Development Ultragenyx, biotech, drugs, pharma, pharmaceutical

Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …

768px-lambs_liver

Research unveils new drug targets for more effective treatment of liver disease

August 22, 2017
Manufacturing and Production, Research and Development life sciences, liver, liver cancer, liver disease, pharma, pharmaceuticals

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

astrazeneca-sign

AstraZeneca strikes mRNA-based partnership in respiratory disease

August 22, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Ethris, MedImmune, mrna, pharma, pharmaceuticals

AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …

The Gateway to Local Adoption Series

Latest content